Science and Regulation
Current Impasse and Future Solutions
Bibliographic Data
We reflect on four articles that examine the Supreme Court’s Daubert v Merrell Dow Pharmaceuticals, Inc decision and efforts by private interests to derail public health and environmental regulations. The articles’ authors make the case that the impact of Daubert and related decisions in court settings pale by comparison to the threat that Daubert-like thinking poses in the regulatory arena. A growing number of companies, however, have made substantial changes in practice and in culture by embracing a philosophy where health and environment are priorities. Mechanisms could be established to encourage firms to pledge to use science to meet public health and environmental goals, as well as channel the ingenuity of the private sector towards ecological, economical, and equitable systems of production
Business · Economics · Environmental ethics · Ingenuity · Pledge · Political science · Public relations · Supreme court · Biomedical Ethics and Regulation · Law · Pharmaceutical industry and healthcare · Public Administration · Regulation and Compliance Studies
Manufacturing Uncertainty
Reenergizing Public Health Through Precaution
Regulatory Parallels to Daubert
The Weight of Scientific Evidence in Policy and Law
The Perils of Relying on Interested Parties to Evaluate Scientific Quality
Daubert and the Proper Role for the Courts in Health, Safety, and Environmental Regulation
Law’s Knowledge
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,17 |
| Citation span | 2020 - 2020 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |